
Yes, GLP-1 weight loss medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are linked to hair shedding, but the medication is usually not attacking your hair directly. The most common cause is telogen effluvium, a temporary shedding that follows rapid weight loss, lower protein intake, or other stress on the body. It typically starts 2 to 4 months after weight loss begins and, in most people, settles within 6 to 12 months. Menopause hair thinning is different: falling estrogen exposes follicles to androgens and causes gradual, ongoing thinning that tends not to resolve on its own.
Both questions surged in Arizona this year. Google Trends showed "GLP-1 hair loss," "does Zepbound cause hair loss," and "menopause hair loss treatment" as breakout searches, alongside steady interest in hair loss in women. This guide from Opal Aesthetics in Pinetop explains what is happening, how to tell the two apart, and which treatments actually help.
Hair grows in cycles. At any time, most follicles are in the growth (anagen) phase and a smaller share are resting (telogen). A significant physical stress can push a large group of follicles into the resting phase at once. A few months later, those hairs shed together. That delayed, diffuse shedding is telogen effluvium.
GLP-1 medications create several of those stressors at the same time:
In clinical trials, hair loss was reported more often in people taking these medications than in those on placebo, and more often at higher doses with faster weight loss. Most cases were mild.
Usually not. Telogen effluvium is generally reversible. The follicles are not destroyed; they are resting. Once weight stabilizes and nutrition is adequate, regrowth typically begins within several months. The exception is when the shedding unmasks an underlying pattern of thinning, such as menopause-related or genetic hair loss, which then needs its own treatment.
During perimenopause and menopause, estrogen and progesterone decline. Those hormones help keep hair in its growth phase longer. As they drop, the relative effect of androgens (like testosterone and DHT) increases on genetically sensitive follicles. Over time, those follicles shrink and produce finer, shorter hairs. This is called female pattern hair loss.
It looks different from GLP-1 shedding:
Many women in their 40s and 50s have both at once, which is why a proper evaluation matters.
Topical minoxidil is FDA approved for female pattern hair loss and remains a first-line option. Low-dose oral minoxidil, a rising search this year, is prescribed off-label by some physicians and needs medical supervision.
For some women, addressing hormonal changes with a qualified provider is part of the solution. Opal can refer you to a trusted functional medicine provider for hormone evaluation.
PRP hair restoration uses platelet-rich plasma from your own blood. The concentrated growth factors are injected into thinning areas of the scalp to stimulate follicles. Published studies show improvement in hair density and thickness for many patients with pattern hair loss. A typical plan is 3 to 4 sessions about a month apart, then maintenance every 4 to 6 months. "PRP hair treatment near me" rose more than 300% in Arizona searches this year.
Alma TED (TransEpidermal Delivery) uses ultrasound and air pressure to drive a hair-growth serum into the scalp without needles. It is comfortable, has no downtime, and is a good fit for patients who dislike injections or want to support regrowth after GLP-1 shedding. Most patients do a series of sessions several weeks apart and see changes over about 3 to 6 months.
Hair loss rarely has one cause, so the best results usually come from layering approaches: nutrition and labs, a medical therapy such as minoxidil, and an in-office treatment like PRP or TED. We build these plans around your history, not a one-size protocol.
Book an evaluation if shedding continues longer than 6 months, if you see patches of hair loss, scalp redness, scaling, or pain, or if your part or crown is clearly widening. Patchy loss or scalp symptoms can signal other conditions that need a dermatologist or physician.
Hair loss has been reported with both tirzepatide (Zepbound, Mounjaro) and semaglutide (Ozempic, Wegovy). It is most often temporary shedding linked to rapid weight loss and nutrition changes rather than a direct effect on follicles.
Shedding usually peaks a few months after weight loss begins and settles within 6 to 12 months as weight stabilizes and nutrition improves.
Menopause-related thinning tends to progress without treatment, but many women see meaningful improvement in density with consistent treatment such as minoxidil, PRP, or TED. Starting early gives the best results.
PRP uses your own growth factors delivered by injection and has a larger body of published research. TED is needle-free and very comfortable. Some patients use both. A consultation helps decide based on your pattern and comfort.
Yes. Both treatments are used for men and women with thinning hair.
Opal Aesthetics offers PRP hair restoration and needle-free Alma TED treatments for women and men across the White Mountains. Care is overseen by owner Caroline Johnson, RN, BSN, under the medical direction of Dr. Cara Slater.
Noticing more hair in the brush than you used to? Book a hair restoration consultation or call (928) 270-2327.
This article is for general education and is not a substitute for medical advice. Talk with the provider who prescribes your medication before making changes.
Stay updated with the latest blog posts and engage with our community.
